Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Risk of lung cancer in lung transplant recipients in the United States.

Triplette M, Crothers K, Mahale P, Yanik EL, Valapour M, Lynch CF, Schabath MB, Castenson D, Engels EA.

Am J Transplant. 2018 Dec 18. doi: 10.1111/ajt.15181. [Epub ahead of print]

PMID:
30565414
2.

Donor-specific Antibodies, Immunoglobulin-free Light Chains, and BAFF Levels in Relation to Risk of Late-onset PTLD in Liver Recipients.

Engels EA, Jennings LW, Everly MJ, Landgren O, Murata K, Yanik EL, Pfeiffer RM, Onaca N, Klintmalm GB.

Transplant Direct. 2018 May 15;4(6):e353. doi: 10.1097/TXD.0000000000000792. eCollection 2018 Jun.

3.

Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada.

Yanik EL, Hernández-Ramírez RU, Qin L, Lin H, Leyden W, Neugebauer RS, Horberg MA, Moore RD, Mathews WC, Justice AC, Hessol NA, Mayor AM, Gill MJ, Brooks JT, Sun J, Althoff KN, Engels EA, Silverberg MJ, Dubrow R.

J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):499-504. doi: 10.1097/QAI.0000000000001719.

PMID:
29771785
4.

Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America.

Engels EA, Yanik EL, Wheeler W, Gill MJ, Shiels MS, Dubrow R, Althoff KN, Silverberg MJ, Brooks JT, Kitahata MM, Goedert JJ, Grover S, Mayor AM, Moore RD, Park LS, Rachlis A, Sigel K, Sterling TR, Thorne JE, Pfeiffer RM; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS.

Clin Infect Dis. 2017 Aug 15;65(4):636-643. doi: 10.1093/cid/cix392.

5.

Contribution of solid organ transplant recipients to the pediatric non-hodgkin lymphoma burden in the United States.

Yanik EL, Shiels MS, Smith JM, Clarke CA, Lynch CF, Kahn AR, Koch L, Pawlish KS, Engels EA.

Cancer. 2017 Dec 1;123(23):4663-4671. doi: 10.1002/cncr.30923. Epub 2017 Jul 31.

6.

Cancer Risk After Pediatric Solid Organ Transplantation.

Yanik EL, Smith JM, Shiels MS, Clarke CA, Lynch CF, Kahn AR, Koch L, Pawlish KS, Engels EA.

Pediatrics. 2017 May;139(5). pii: e20163893. doi: 10.1542/peds.2016-3893.

7.

Incidence of Cancer in Spinal Deformity Patients Receiving High-Dose (≥40 mg) Bone Morphogenetic Protein (rhBMP-2).

Baldus C, Kelly MP, Yanik EL, Drake BF, Ahmad A, Mesfin A, Bridwell KH.

Spine (Phila Pa 1976). 2017 Dec 1;42(23):1785-1791. doi: 10.1097/BRS.0000000000002232.

PMID:
28498289
8.

RE: The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study.

Engels EA, Parsons R, Besson C, Morton LM, Yanik EL, Arem H, Pfeiffer RM.

J Natl Cancer Inst. 2017 Apr 1;109(4). doi: 10.1093/jnci/djx026. No abstract available.

9.

Risk of Thyroid Cancer Among Solid Organ Transplant Recipients.

Kitahara CM, Yanik EL, Ladenson PW, Hernandez BY, Lynch CF, Pawlish KS, Engels EA.

Am J Transplant. 2017 Nov;17(11):2911-2921. doi: 10.1111/ajt.14310. Epub 2017 May 30.

10.

Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States.

Yanik EL, Pfeiffer RM, Freedman DM, Weinstock MA, Cahoon EK, Arron ST, Chaloux M, Connolly MK, Nagarajan P, Engels EA.

Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):998-1007. doi: 10.1158/1055-9965.EPI-17-0003. Epub 2017 Apr 4.

11.

Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.

Kreimer AR, Johansson M, Yanik EL, Katki HA, Check DP, Lang Kuhs KA, Willhauck-Fleckenstein M, Holzinger D, Hildesheim A, Pfeiffer R, Williams C, Freedman ND, Huang WY, Purdue MP, Michel A, Pawlita M, Brennan P, Waterboer T.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx005.

12.

Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for Immunotherapy.

Yanik EL, Kaunitz GJ, Cottrell TR, Succaria F, McMiller TL, Ascierto ML, Esandrio J, Xu H, Ogurtsova A, Cornish T, Lipson EJ, Topalian SL, Engels EA, Taube JM.

JAMA Oncol. 2017 Jul 1;3(7):974-978. doi: 10.1001/jamaoncol.2017.0115.

13.
14.

Skin cancer in the end-stage renal disease population: unique risk factors for patients on dialysis.

Yanik EL.

Br J Dermatol. 2016 Dec;175(6):1136-1137. doi: 10.1111/bjd.15032. No abstract available.

PMID:
27996124
15.

Cancer risk among lung transplant recipients with cystic fibrosis.

Fink AK, Yanik EL, Marshall BC, Wilschanski M, Lynch CF, Austin AA, Copeland G, Safaeian M, Engels EA.

J Cyst Fibros. 2017 Jan;16(1):91-97. doi: 10.1016/j.jcf.2016.07.011. Epub 2016 Aug 15.

16.

Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.

Yanik EL, Achenbach CJ, Gopal S, Coghill AE, Cole SR, Eron JJ, Moore RD, Mathews WC, Drozd DR, Hamdan A, Ballestas ME, Engels EA.

J Clin Oncol. 2016 Sep 20;34(27):3276-83. doi: 10.1200/JCO.2016.67.6999. Epub 2016 Aug 9.

17.

Bone Morphogenetic Protein Use and Cancer Risk Among Patients Undergoing Lumbar Arthrodesis: A Case-Cohort Study Using the SEER-Medicare Database.

Beachler DC, Yanik EL, Martin BI, Pfeiffer RM, Mirza SK, Deyo RA, Engels EA.

J Bone Joint Surg Am. 2016 Jul 6;98(13):1064-72. doi: 10.2106/JBJS.15.01106.

18.

Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").

Engels EA, Parsons R, Besson C, Morton LM, Enewold L, Ricker W, Yanik EL, Arem H, Austin AA, Pfeiffer RM.

Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1105-13. doi: 10.1158/1055-9965.EPI-16-0212. Epub 2016 Apr 26.

19.

Risk of Renal Cell Carcinoma Among Kidney Transplant Recipients in the United States.

Karami S, Yanik EL, Moore LE, Pfeiffer RM, Copeland G, Gonsalves L, Hernandez BY, Lynch CF, Pawlish K, Engels EA.

Am J Transplant. 2016 Dec;16(12):3479-3489. doi: 10.1111/ajt.13862. Epub 2016 Jun 23.

20.

Comparison of Cancer Diagnoses Between the US Solid Organ Transplant Registry and Linked Central Cancer Registries.

Yanik EL, Nogueira LM, Koch L, Copeland G, Lynch CF, Pawlish KS, Finch JL, Kahn AR, Hernandez BY, Segev DL, Pfeiffer RM, Snyder JJ, Kasiske BL, Engels EA.

Am J Transplant. 2016 Oct;16(10):2986-2993. doi: 10.1111/ajt.13818. Epub 2016 May 12.

21.

Trends in primary central nervous system lymphoma incidence and survival in the U.S.

Shiels MS, Pfeiffer RM, Besson C, Clarke CA, Morton LM, Nogueira L, Pawlish K, Yanik EL, Suneja G, Engels EA.

Br J Haematol. 2016 Aug;174(3):417-24. doi: 10.1111/bjh.14073. Epub 2016 Mar 28.

22.

Cancer risk among the HIV-infected elderly in the United States.

Yanik EL, Katki HA, Engels EA.

AIDS. 2016 Jun 19;30(10):1663-8. doi: 10.1097/QAD.0000000000001077.

23.

Melanoma Outcomes in Transplant Recipients With Pretransplant Melanoma.

Arron ST, Raymond AK, Yanik EL, Castenson D, McCulloch CE, Clarke CA, Paddock LE, Niu X, Engels EA.

Dermatol Surg. 2016 Feb;42(2):157-66. doi: 10.1097/DSS.0000000000000602.

24.

Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma.

Yanik EL, Chinnakotla S, Gustafson SK, Snyder JJ, Israni AK, Segev DL, Engels EA.

Liver Transpl. 2016 May;22(5):627-34. doi: 10.1002/lt.24395.

25.

Herpes Zoster and Risk of Cancer in the Elderly U.S. Population.

Mahale P, Yanik EL, Engels EA.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):28-35. doi: 10.1158/1055-9965.EPI-15-1033. Epub 2015 Nov 17.

26.

Variation in Cancer Incidence among Patients with ESRD during Kidney Function and Nonfunction Intervals.

Yanik EL, Clarke CA, Snyder JJ, Pfeiffer RM, Engels EA.

J Am Soc Nephrol. 2016 May;27(5):1495-504. doi: 10.1681/ASN.2015040373. Epub 2015 Nov 12.

27.

Melanoma Risk and Survival among Organ Transplant Recipients.

Robbins HA, Clarke CA, Arron ST, Tatalovich Z, Kahn AR, Hernandez BY, Paddock L, Yanik EL, Lynch CF, Kasiske BL, Snyder J, Engels EA.

J Invest Dermatol. 2015 Nov;135(11):2657-2665. doi: 10.1038/jid.2015.312. Epub 2015 Aug 13.

28.

Leukoplakia, Oral Cavity Cancer Risk, and Cancer Survival in the U.S. Elderly.

Yanik EL, Katki HA, Silverberg MJ, Manos MM, Engels EA, Chaturvedi AK.

Cancer Prev Res (Phila). 2015 Sep;8(9):857-63. doi: 10.1158/1940-6207.CAPR-15-0091. Epub 2015 Jul 9.

29.

Sirolimus effects on cancer incidence after kidney transplantation: a meta-analysis.

Yanik EL, Siddiqui K, Engels EA.

Cancer Med. 2015 Sep;4(9):1448-59. doi: 10.1002/cam4.487. Epub 2015 Jun 24.

30.

Sirolimus use and cancer incidence among US kidney transplant recipients.

Yanik EL, Gustafson SK, Kasiske BL, Israni AK, Snyder JJ, Hess GP, Engels EA, Segev DL.

Am J Transplant. 2015 Jan;15(1):129-36. doi: 10.1111/ajt.12969. Epub 2014 Dec 17.

31.

Reply to P. De Paoli et al.

Gopal S, Achenbach CJ, Yanik EL, Dittmer DP, Eron JJ, Engels EA.

J Clin Oncol. 2014 Sep 20;32(27):3079. No abstract available.

PMID:
25002715
32.

Lymphoma immune reconstitution inflammatory syndrome in the center for AIDS research network of integrated clinical systems cohort.

Gopal S, Patel MR, Achenbach CJ, Yanik EL, Cole SR, Napravnik S, Burkholder GA, Mathews WC, Rodriguez B, Deeks SG, Mayer KH, Moore RD, Kitahata MM, Richards KL, Eron JJ.

Clin Infect Dis. 2014 Jul 15;59(2):279-86. doi: 10.1093/cid/ciu270. Epub 2014 Apr 21.

33.

Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence.

Yanik EL, Napravnik S, Cole SR, Achenbach CJ, Gopal S, Dittmer DP, Olshan AF, Kitahata MM, Mugavero MJ, Saag M, Moore RD, Mathews WC, Hunt P, Eron JJ.

AIDS. 2014 Apr 24;28(7):979-87. doi: 10.1097/QAD.0000000000000167.

34.

Moving forward in HIV-associated cancer.

Gopal S, Achenbach CJ, Yanik EL, Dittmer DP, Eron JJ, Engels EA.

J Clin Oncol. 2014 Mar 20;32(9):876-80. doi: 10.1200/JCO.2013.53.1376. Epub 2014 Feb 18. No abstract available.

35.

Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.

Gopal S, Patel MR, Yanik EL, Cole SR, Achenbach CJ, Napravnik S, Burkholder GA, Reid EG, Rodriguez B, Deeks SG, Mayer KH, Moore RD, Kitahata MM, Eron JJ, Richards KL.

J Natl Cancer Inst. 2013 Aug 21;105(16):1221-9. doi: 10.1093/jnci/djt158. Epub 2013 Jul 26.

36.

Association of early HIV viremia with mortality after HIV-associated lymphoma.

Gopal S, Patel MR, Yanik EL, Cole SR, Achenbach CJ, Napravnik S, Burkholder GA, Reid EG, Rodriguez B, Deeks SG, Mayer KH, Moore RD, Kitahata MM, Richards KL, Eron JJ.

AIDS. 2013 Sep 24;27(15):2365-73. doi: 10.1097/QAD.0b013e3283635232.

37.

Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy.

Yanik EL, Napravnik S, Cole SR, Achenbach CJ, Gopal S, Olshan A, Dittmer DP, Kitahata MM, Mugavero MJ, Saag M, Moore RD, Mayer K, Mathews WC, Hunt PW, Rodriguez B, Eron JJ.

Clin Infect Dis. 2013 Sep;57(5):756-64. doi: 10.1093/cid/cit369. Epub 2013 Jun 4.

38.

Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011.

Yanik EL, Tamburro K, Eron JJ, Damania B, Napravnik S, Dittmer DP.

Infect Agent Cancer. 2013 May 24;8(1):18. doi: 10.1186/1750-9378-8-18.

39.

Hematologic, hepatic, renal, and lipid laboratory monitoring after initiation of combination antiretroviral therapy in the United States, 2000-2010.

Yanik EL, Napravnik S, Ryscavage P, Eron JJ, Koletar SL, Moore RD, Zinski A, Cole SR, Hunt P, Crane HM, Kahn J, Mathews WC, Mayer KH, Taiwo BO; Center for Aids Research Network of Integrated Clinical Systems (CNICS) Cohort Study.

J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):216-20. doi: 10.1097/QAI.0b013e31828d69f1.

40.

Evidence for risk stratification when monitoring for toxicities following initiation of combination antiretroviral therapy.

Taiwo B, Yanik EL, Napravnik S, Ryscavage P, Koletar SL, Moore R, Mathews WC, Crane HM, Mayer K, Zinski A, Kahn JS, Eron JJ; CFAR Network of Integrated Clinical Systems (CNICS) Cohort Study.

AIDS. 2013 Jun 19;27(10):1593-602. doi: 10.1097/QAD.0b013e3283601115.

41.

Prevalence of transmitted antiretroviral drug resistance differs between acutely and chronically HIV-infected patients.

Yanik EL, Napravnik S, Hurt CB, Dennis A, Quinlivan EB, Sebastian J, Kuruc JD, Eron JJ.

J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):258-62.

42.

HIV and proteinuria in an injection drug user population.

Yanik EL, Lucas GM, Vlahov D, Kirk GD, Mehta SH.

Clin J Am Soc Nephrol. 2010 Oct;5(10):1836-43. doi: 10.2215/CJN.01030210. Epub 2010 Aug 12.

43.

Daily supplementation with iron plus folic acid, zinc, and their combination is not associated with younger age at first walking unassisted in malnourished preschool children from a deficient population in rural Nepal.

Katz J, Khatry SK, Leclerq SC, Mullany LC, Yanik EL, Stoltzfus RJ, Siegel EH, Tielsch JM.

J Nutr. 2010 Jul;140(7):1317-21. doi: 10.3945/jn.109.119925. Epub 2010 May 19.

44.

Exposure to indoor biomass fuel and tobacco smoke and risk of adverse reproductive outcomes, mortality, respiratory morbidity and growth among newborn infants in south India.

Tielsch JM, Katz J, Thulasiraj RD, Coles CL, Sheeladevi S, Yanik EL, Rahmathullah L.

Int J Epidemiol. 2009 Oct;38(5):1351-63. doi: 10.1093/ije/dyp286. Epub 2009 Sep 16.

PMID:
19759098
45.

Risk factors for maternal night blindness in rural South India.

Katz J, Tielsch JM, Thulasiraj RD, Coles C, Sheeladevi S, Yanik EL, Rahmathullah L.

Ophthalmic Epidemiol. 2009 May-Jun;16(3):193-7. doi: 10.1080/09286580902863080.

Supplemental Content

Loading ...
Support Center